Opportunities in targeted drug delivery to Kupffer cells: delivery of immunomodulators to Kupffer cells-activation of tumoricidal properties
- 31 October 1995
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 17 (1), 21-30
- https://doi.org/10.1016/0169-409x(95)00038-9
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Heterogeneity in secretory responses of rat liver macrophages of different sizeLiver International, 1995
- The role of Kupffer cells in the differentiation process of hepatic natural killer cellsHepatology, 1995
- Chemoimmunotherapy of Murine Liver Metastases with 5-Fluorouracil in Combination with Liposome-Encapsulated Muramyl DipeptideJournal of Immunotherapy, 1993
- Liposomes containing lipid A as a potent non-toxic adjuvantResearch in Immunology, 1992
- The effect of liver macrophages on in vitro cytolytic activity of 5FU and FUDR on colon carcinoma cells: Evidence of macrophage activationInternational Journal of Immunopharmacology, 1992
- Liposomal muramyl dipeptide therapy of experimental M5076 liver metastases in miceCancer Immunology, Immunotherapy, 1991
- Anti-metastatic activity in vivo of MDP-l-alanyl-cholesterol (MTP-Chol) entrapped in nanocapsulesInternational Journal of Immunopharmacology, 1991
- Activation of murine kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptideHepatology, 1988
- Importance of Local Proliferation in the Expanding Kupffer Cell Population of Rat Liver After Zymosan Stimulation and Partial HepatectomyHepatology, 1984
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974